Neutrogena Ultra Sheer Body Mist Sunscreen Recall for cGMP Deviations
Johnson & Johnson Consumer, Inc. is voluntarily recalling Neutrogena Ultra Sheer body mist sunscreen SPF 70 (5.0 oz aerosol cans) due to cGMP manufacturing deviations. The product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall, and the source text explicitly states no illnesses or injuries have been reported. The hazard is a cGMP deviation, which represents a manufacturing/quality control issue rather than an acute safety threat. Per the rubric, FDA Class II recalls without reported harm or high-risk pathogens fall in the Moderate range.
Plain-English summary
Johnson & Johnson Consumer, Inc. is voluntarily recalling approximately 2,724,480 cans of Neutrogena Ultra Sheer body mist sunscreen BROAD SPECTRUM SPF 70 (Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%), NET WT. 5.0 OZ (141 g) aerosol can (UPC 0 86800 10040 9). The recall was initiated by the firm on July 14, 2021, and the FDA classified it as a Class II recall on September 24, 2021.
The product is being recalled due to cGMP (current Good Manufacturing Practice) deviations identified during manufacturing. All lots within the product's expiration date are affected.
The product was distributed nationwide in the United States. Consumers who have purchased this product should stop using it and may contact Johnson & Johnson Consumer, Inc. for further information regarding the recall.
The recalled product
- Product
- Neutrogena Ultra Sheer body mist sunscreen BROAD SPECTRUM SPF 70, Avobenzone (3%), Homosalate (15%), Octisalate (5%), Octocrylene (10%), NET WT. 5.0 OZ (141 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 10040 9
- Manufacturer
- Johnson & Johnson Consumer, Inc.
- Category
- Drug — Sunscreen / Topical Drug
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27